Wilmot Cancer institute patients may be offered several treatment options for their type and stage of cancer. One option may include participation in a clinical trial, and often, clinical trials are the best option.
Clinical trials – sometimes called “clinical studies” or “research protocols” -- seek to answer questions that may lead to better ways of preventing, diagnosing, and treating cancer. Clinical trials can also study ways to improve quality of life, behavioral and psychosocial impacts of cancer and genetic questions that researchers would like to answer.
Wilmot’s clinical trials are developed and sponsored by our own physicians and researchers, major pharmaceutical companies, or national cooperative programs funded by the National Cancer Institute (NCI). Most trials have eligibility requirements, which can be explained by your doctor, oncology nurse, or clinical study coordinator.
Choosing to participate in a clinical trial is an important, personal decision and one that only a patient can make with the help of physicians, family members and friends.